{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:23:03Z","timestamp":1791922983591,"version":"4.3.4"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["22K08038"],"award-info":[{"award-number":["22K08038"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["22K15974"],"award-info":[{"award-number":["22K15974"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.cgh.2026.04.026","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:04:45Z","timestamp":1778285085000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Polygenic Risk Score Predicts Prognosis in Nonobese Metabolic Dysfunction-Associated Steatotic Liver Disease but not in Obese Metabolic Dysfunction-Associated Steatotic Liver Disease in Japan: A Multicenter Cohort Study"],"prefix":"10.1016","author":[{"given":"Takao","family":"Shirono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michihiro","family":"Iwaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3658-5894","authenticated-orcid":false,"given":"Yuya","family":"Seko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Won","family":"Jun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihide","family":"Shima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miwa","family":"Kawanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saiyu","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanji","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Yoneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshito","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Okanoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2026.04.026_bib1","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for NAFLD\/MASLD","volume":"79","author":"Wong","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2026.04.026_bib2","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2026.04.026_bib3","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"5","author":"Ye","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.04.026_bib4","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1016\/j.cgh.2022.11.019","article-title":"Mortality and liver-related events in lean versus non-lean nonalcoholic Fatty liver disease: a systematic review and meta-analysis","volume":"21","author":"Ha","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.04.026_bib5","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/apt.17424","article-title":"Higher mortality among lean patients with non-alcoholic fatty liver disease despite fewer metabolic comorbidities","volume":"57","author":"Wijarnpreecha","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2026.04.026_bib6","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/jgh3.12808","article-title":"Comparison of long-term prognosis between non-obese and obese patients with non-alcoholic fatty liver disease","volume":"6","author":"Iwaki","year":"2022","journal-title":"JGH Open"},{"key":"10.1016\/j.cgh.2026.04.026_bib7","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1111\/liv.15678","article-title":"The greater impact of PNPLA3 polymorphism on liver-related events in Japanese non-alcoholic fatty liver disease patients: a multicentre cohort study","volume":"43","author":"Seko","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2026.04.026_bib8","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.cgh.2024.02.031","article-title":"Differential effects of genetic polymorphism on comorbid disease in metabolic dysfunction-associated steatotic liver disease","volume":"22","author":"Seko","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.04.026_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/liv.16124","article-title":"Clinical utility of genetic variants in PNPLA3 and TM6SF2 to predict liver-related events in metabolic dysfunction-associated steatotic liver disease","volume":"45","author":"Seko","year":"2025","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2026.04.026_bib10","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.cgh.2021.05.056","article-title":"A polygenic risk score to refine risk stratification and prediction for severe liver disease by clinical fibrosis scores","volume":"20","author":"De Vincentis","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.04.026_bib11","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jhep.2020.11.024","article-title":"Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores","volume":"74","author":"Bianco","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2026.04.026_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2024.101288","article-title":"Lean non-alcoholic fatty liver disease and the risk of all-cause mortality: an updated meta-analysis","volume":"29","author":"Wongtrakul","year":"2024","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.cgh.2026.04.026_bib13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.eprac.2022.10.007","article-title":"A meta-analysis on associated risk of mortality in nonalcoholic fatty liver disease","volume":"29","author":"Fu","year":"2023","journal-title":"Endocr Pract"},{"key":"10.1016\/j.cgh.2026.04.026_bib14","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1007\/s10620-024-08764-4","article-title":"Mortality, hepatic decompensation, and cardiovascular outcomes in lean vs. non-lean MASLD cirrhosis: a Veterans affairs cohort study","volume":"70","author":"Njei","year":"2025","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2026.04.026_bib15","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1016\/j.cgh.2023.04.024","article-title":"Impact of PNPLA3 rs738409 polymorphism on the development of liver-related events in patients with nonalcoholic fatty liver disease","volume":"21","author":"Rosso","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.04.026_bib16","doi-asserted-by":"crossref","DOI":"10.1111\/liv.16164","article-title":"Impact of PNPLA3 in lean individuals and in cryptogenic steatotic liver disease","volume":"45","author":"Seko","year":"2025","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2026.04.026_bib17","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/hep.31238","article-title":"Combined effect of PNPLA3, TM6SF2, and HSD17B13 variants on risk of cirrhosis and hepatocellular carcinoma in the general population","volume":"72","author":"Gellert-Kristensen","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2026.04.026_bib18","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1111\/liv.15629","article-title":"Genetic risk of fatty liver disease and mortality in the general population: a Mendelian randomization study","volume":"43","author":"Gellert-Kristensen","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2026.04.026_bib19","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1111\/liv.15438","article-title":"Effect of common genetic variants on the risk of cirrhosis in non-alcoholic fatty liver disease during 20 years of follow-up","volume":"42","author":"Holmer","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2026.04.026_bib20","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/apt.16772","article-title":"NAFLD-related gene polymorphisms and all-cause and cause-specific mortality in an Asian population: the Shanghai Changfeng Study","volume":"55","author":"Xia","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2026.04.026_bib21","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2026.04.026_bib22","article-title":"Non-alcoholic fatty liver disease: a patient guideline","volume":"3","author":"Francque","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.cgh.2026.04.026_bib23","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa2413258","article-title":"Phase 3 trial of semaglutide in metabolic dysfunction-associated steatohepatitis","volume":"392","author":"Sanyal","year":"2025","journal-title":"N Engl J Med"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356526003332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356526003332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:41:25Z","timestamp":1783024885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356526003332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":23,"alternative-id":["S1542356526003332"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2026.04.026","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polygenic Risk Score Predicts Prognosis in Nonobese Metabolic Dysfunction-Associated Steatotic Liver Disease but not in Obese Metabolic Dysfunction-Associated Steatotic Liver Disease in Japan: A Multicenter Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2026.04.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Gastroenterological Association Institute. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}